1 s2.0 S1110663815000592 Main
1 s2.0 S1110663815000592 Main
1 s2.0 S1110663815000592 Main
net/publication/298338303
CITATIONS READS
22 324
3 authors, including:
All content following this page was uploaded by Omar Atef Tolba on 03 November 2016.
a
Department of Pediatrics, Al-Azhar University, Egypt
b
Cairo University Children’s Hospital, Department of Pediatrics, Cairo University, Egypt
KEYWORDS Abstract Background and objectives: Serum magnesium is involved in the pathogenesis of obesity
Magnesium; and its related diseases. The aim of the present study was to evaluate serum magnesium status in
Obesity; obese children and adolescents and to study its relationship with the degree of obesity and serum
Children; lipid profile.
Adolescents; Design and settings: A cross-sectional study was conducted at the general pediatric out-patient
Serum lipid profile clinic of a university hospital, over a period of 5 months from May to September 2013.
Methods: 50 obese subjects of ages 2–16 years and 50 healthy normal weight subjects of matched
age and sex as controls were consecutively enrolled. Comprehensive history, anthropometric mea-
surements and blood pressure were taken. BMI and degree of obesity were calculated. Fasting total
serum magnesium, total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides were mea-
sured.
Results: Obese cases compared to normal weight controls showed significantly lower serum mag-
nesium and HDL-cholesterol levels and significantly higher total cholesterol, LDL-cholesterol,
triglycerides, systolic and diastolic blood pressures. Serum magnesium showed a significant, strong
inverse correlation with the degree of obesity (r = 0.8, p < 0.001); significant, moderate inverse
correlation with total cholesterol and LDL-cholesterol; and non-significant correlation with triglyc-
erides and HDL-cholesterol. The degree of obesity showed a significant, moderate positive correla-
tion with total cholesterol and LDL-cholesterol and a non-significant correlation with triglycerides
and HDL-cholesterol.
Conclusion: Serum magnesium levels are inversely correlated with the degree of obesity, and is
related to an unfavorable serum lipid profile in obese children and adolescents, who also show a
trend to higher systemic blood pressure.
Ó 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
* Corresponding author at: Department of Pediatrics, Cairo University Children’s Hospital, Cairo University, 50 Lebanon Street, El
Mohandessin, 12411 Giza, Egypt. Tel.: +20 1222101717, +20 233025539.
E-mail addresses: alizaakook@hotmail.com (A.M. Zaakouk), mapissar@gmail.com (M.A. Hassan), omartolba80@yahoo.com (O.A. Tolba).
Peer review under responsibility of Egyptian Pediatric Association Gazette.
http://dx.doi.org/10.1016/j.epag.2015.11.002
1110-6638 Ó 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric Association.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Serum magnesium status and obesity 33
and weight status was considered normal, overweight or obese Pearson product moment was used to estimate correlation
as mentioned above.21 between variables. p-value < 0.05 was considered statistically
IBW was calculated as IBW = [BMI at the 50th percentile significant.
for that subject’s age (Height in m)2] based on BMI Method.
Percent IBW was calculated as [(actual body weight/IBW) Results
100].23,24
Degree of obesity was assessed by %IBW. Subjects with Table 1 presents the demographic and clinical characteristics
weights > 120% IBW were considered to be obese.23,24 of the two groups. Both groups were comparable regarding
Blood pressure measurements: BP was measured in dupli- age (p = 0.416), sex (p = 0.548), family history of obesity
cates using a mercury sphygmomanometer with appropriate- (p = 0.117) and consumption of Mg-rich foods (p = 0.053).
sized cuffs from the right arm in the sitting position after the Obese cases had significantly higher weight, height, and BMI
subject had rested for five minutes. Hypertension is defined percentiles; and waist circumference measurement (p < 0.001
as a BP greater than the 95th percentile specific for age and for all). Also, they had significantly higher percentiles of sys-
gender.25 tolic and diastolic blood pressure compared to the non-obese
controls (p < 0.001 and p = 0.034, respectively).
Biochemical tests Compared to the non-obese control subjects, the obese
Venous blood samples were obtained after an overnight fast of cases had significantly lower serum Mg concentration and
12–14 h for estimation of serum magnesium (Mg), total choles- HDL-C (p < 0.001) and significantly higher fasting TC,
terol (TC), low-density lipoprotein-cholesterol (LDL-C), high- LDL-C, and TG (p < 0.001 for all except TG p = 0.002)
density lipoprotein-cholesterol (HDL-C), and triglycerides (Table 2).
(TG) in all subjects. A statistically significant, strong inverse correlation was
Serum Mg was measured spectrophotometrically using found between serum Mg concentration and the degree of obe-
ready for use kit (HumanÒ Company, Germany). Serum Mg sity (r = 0.8, p < 0.001) (Fig. 1).
levels (mg/dL) were calculated according to the formula: ion- As shown in Table 3, in the obese cases serum Mg had a sig-
ized Mg in mmol/L = [0.66 (total Mg in mmol/L)] nificant moderate inverse correlation with TC and LDL-C
+ 0.039.26 (r = 0.412, p = 0.003 and r = 0.311, p = 0.028;
TC, TG and HDL-C were measured using standard meth- respectively), non-significant inverse correlation with TG
ods. LDL-C was calculated using Friedewald’s formula.27 Cal-
culation was valid only when TG were <400 mg/dL.
Thresholds for normal biochemical values were as follows:
serum Mg concentration of 1.5–2.3 mg/dL 28,29; fasting TC of Table 2 Biochemical data of obese cases and non-obese
<170 mg/dL; HDL-C of >45 mg/dL; LDL-C of <110 mg/dL; controls.
and TG of <75 mg/dL for ages 0–9 years and <90 mg/dL
Variable (mg/dL) Obese Non-obese p value
for ages 10–19 years.30,31 (n = 50) (n = 50)
Serum 1.5 ± 0.5 2.4 ± 0.3 <0.001
Statistical analysis
magnesium
Data were analyzed using IBM SPSS Advanced Statistics ver- Total cholesterol 190.2 ± 25.6 130.0 ± 30.8 <0.001
sion 20.0 (IBMÓ Corp., Armonk, NY, USA). Numerical data LDL-cholesterol 142.6 ± 26.3 91.1 ± 17.5 <0.001
were expressed as mean, standard deviation, and range. Triglycerides 107.1 ± 17.0 94.4 ± 22.3 0.002
Qualitative data were expressed as frequency and percentage. HDL-cholesterol 51.3 ± 7.5 59.4 ± 11.4 <0.001
Chi-square test was used to examine the relation between the Data are expressed as mean ± standard deviation.
qualitative variables. For quantitative data, comparison Statistical analysis by: t-test for independent samples.
between 2 groups was done using independent sample t-test.
Table 1 Demographic and clinical characteristics of obese cases and non-obese controls.
Variable Obese (n = 50) Non-obese (n = 50) p value
Age (years) 9.3 ± 2.4 9.7 ± 2.5 0.416
Sex (male/female) 23/27 26/24 0.548y
Family history of obesity 6 (12%) 1 (2%) 0.117y
Eating food rich in magnesium 15 (30%) 7 (14%) 0.053y
Weight for age percentiles–sex specific 95.8 ± 6.2 41.0 ± 10.2 <0.001
Height for age percentiles–sex specific 42.4 ± 9.1 22.0 ± 6.1 <0.001
BMI for age percentiles–sex specific 98.7 ± 1.2 49.5 ± 8.7 <0.001
Waist circumference (cm) 90.9 ± 13.0 69.0 ± 9.7 <0.001
Systolic BP percentiles (mm Hg) 58.4 ± 11.6 45.0 ± 9.8 <0.001
Diastolic BP percentiles (mm Hg) 62.2 ± 9.9 57.4 ± 12.3 0.034
BMI: body mass index, BP: blood pressure.
Data are expressed as mean ± standard deviation or frequency and (percentage).
Statistical analysis by: t-test for independent samples or yChi-square test.
Serum magnesium status and obesity 35
r = - 0.8
P < 0.001
Serum Mg (mg/dL)
Also this is coupled with a propensity of obese cases to have 12. Morrison JA, Ford ES, Steinberger J. The pediatric metabolic
significantly higher mean systolic and diastolic blood pressure syndrome. Minerva Med 2008;99(3):269–87.
centiles than non-obese controls. According to epidemiologic 13. Inoue I. Lipid metabolism and magnesium. Clin Calcium 2005;15
surveys of children and adolescents over the past 20 years, (11):65–79.
14. Rosolova H, Mayer Jr O, Reaven GM. Insulin-mediated glucose
BP levels have been increasing, and the prevalence of hyperten-
disposal is decreased in normal subjects with relatively low plasma
sion and prehypertension are also increasing, explained par- magnesium concentrations. Metabolism 2000;49(3):418–20.
tially by the rise in obesity rates.30 15. Volpe SL. Magnesium in disease prevention and overall health.
Adv Nutr 2013;4:378S–83S.
Conclusion 16. Sui X, Church TS, Meriwether RA. Uric acid and the development
of metabolic syndrome in women and men. Metabolism 2008;57:
845–52.
This study observes lower serum Mg with an inverse correla-
17. Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Wettman
tion with the degree of obesity, serum total cholesterol and YF, Holmes YF, et al. Magnesium deficiency is associated with
LDL-cholesterol, along with a trend to higher systemic blood insulin resistance in obese children. Diabetes Care 2005;28:
pressure among obese children and adolescents. Therefore, 1175–81.
serum Mg can be used as an early biomarker for obesity- 18. Kurpad AV, Aeberli I. Low serum magnesium and obesity –
related morbidities. Further investigations are recommended causal role or diet biomarker? Indian Pediatr 2012;49:100–1.
to identify the possible etiology of such derangement, as Mg 19. Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude K.
dietary intake was noted to be higher in Mg-deficient subjects, Determination of intracellular free magnesium by nuclear mag-
which points to a metabolic error being either a cofactor in the netic resonance in human magnesium deficiency. J Am Coll Nutr
1989;8:580–7.
pathogenesis of obesity or a consequence. Such findings might
20. Witkowski M, Hubert J, Mazur A. Methods of assessment of
be of significance in fighting the obesity epidemic and its mul-
magnesium status in humans: a systematic review. Magnes Res
tisystem complications. 2011;24:163–80.
21. Ghalli I, Salah N, Hussien F, Erfan M, El-Ruby M, Mazen I, et al.
Conflict of interest Egyptian growth curves 2002 for infants, children and adolescents.
In: Sartorio A, Buckler JMH, Marazzi N, editors. Crescere nel
mondo. Italy: Ferring publisher; 2008.
The authors declare no conflict of interest.
22. Tzamaloukas AH, Leger A, Hill J, Murata GH. Body mass index
in patients with amputation on peritoneal dialysis: error of
References uncorrected estimates and proposed correction. Adv Perit Dial
2000;16:138–42.
1. Ogden C, Carroll M, Curtin L, Lamb M, Flegal K. Prevalence of 23. Maqbool A, Olsen IE, Stallings VA. Clinical assessment of
high body mass index in US children and adolescents, 2007–2008. nutritional status. In: Duggan C, Watkins JB, Walker WA,
JAMA 2010;303:242–9. editors. Nutrition in pediatrics: basic science and clinical applica-
2. El-Zanaty Fatma, Way Ann. Egypt demographic and health survey tions. 4th ed. Hamilton, Ontario: BC Becker Inc.; 2008. p. 5–13.
2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, 24. Phillips S, Edlbeck A, Kirby M, Goday P. Ideal body weight in
and Macro International; 2009. children. Nutr Clin Pract 2007;22(2):240–5.
3. Manyanga T, El-Sayed H, Doku DT, Randall JR. The prevalence 25. National High Blood Pressure Education Program Working
of underweight, overweight, obesity and associated risk factors Group on High Blood Pressure in Children and Adolescents.
among school-going adolescents in seven African countries. BMC The fourth report on the diagnosis, evaluation, and treatment of
Public Health 2014;14:887. high blood pressure in children and adolescents. Pediatrics
4. Gungor NK. Overweight and obesity in children and adolescents. 2004;114(Suppl. 2):555–76.
J Clin Res Pediatr Endocrinol 2014;6(3):129–43. 26. Koch SM, Warters RD, Mehlhorn U. The simultaneous
5. American Academy of Child and Adolescent Psychiatry measurement of ionized and total calcium and ionized and total
(AACAP). Obesity in Children and Teens. Facts for Families magnesium in intensive care unit patients. J Crit Care 2002;17(3):
2011;79:3/11. 203–5.
6. Bhalavi V, Deshmukh P, Atram M, Mahajan B. Study of 27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the
hypertension and hyperlipidemia in the adolescent of central concentration of low-density lipoprotein cholesterol in plasma,
India. Int J Recent Trends Sci Technol 2014;10(3):495–8. without use of the preparative ultracentrifuge. Clin Chem 1972;18
7. Niranjan G, Anitha D, Srinivasan AR, Velu VK, Venkatesh C, (6):499–502.
Babu MS, et al. Association of inflammatory sialoproteins, lipid 28. Lo SF. Reference intervals for laboratory tests and procedures. In:
peroxides and serum magnesium levels with cardiometabolic risk Kliegman RM, Stanton BF, St Geme JW, Schor NF, editors.
factors in obese children of South Indian population. Int J Biomed Nelson textbook of pediatrics. 20th ed. Philadelphia PA: Elsevier
Sci 2014;10(2):118–23. Inc.; 2015. p. 3470.
8. Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: a 29. Greenbaum LA. Magnesium: electrolyte and acid-base disorders.
review. World J Diabetes 2010;1(3):76–88. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, editors.
9. Charradi K, Elkahoui S, Limam F, Aouani E. High-fat diet Nelson textbook of pediatrics. 20th ed. Philadelphia PA: Elsevier
induced an oxidative stress in white adipose tissue and disturbed Inc.; 2015. p. 362.
plasma transition metals in rat: prevention by grape seed and skin 30. Expert panel on integrated guidelines for cardiovascular health
extract. J Physiol Sci 2013;63(6):445–55. and risk reduction in children and adolescents: summary report.
10. Vehkala L, Ukkola O, Kesäniemi YA, Kähönen M, Nieminen Pediatrics 2011;128(Suppl. 5):S213–56.
A, Jula A, et al. Plasma IgA antibody levels to malondialdehyde 31. Bamba V. Update on screening, etiology and treatment of
acetaldehyde-adducts are associated with inflammatory mediators, dyslipidemia in children. J Clin Endocrinol Metab 2014;99
obesity and type 2 diabetes. Ann Med 2013;45(8):501–10. (9):3093–102.
11. Arsaln N, Erdur B, Aydin A. Hormones and cytokines in 32. Garcia OP, Long KZ, Rosado JL. Impact of micronutrient
childhood obesity. Indian Pediatr 2010;47(10):829–39. deficiencies on obesity. Nutr Rev 2009;67:559–72.
Serum magnesium status and obesity 37
33. Suliburska J, Bogdanski P, Pupek-Musialik D, Krejpcio Z. 38. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes,
Dietary intake and serum and hair concentrations of minerals and cardiovascular risk in children. An American Heart
and their relationship with serum lipids and glucose levels in Association Scientific Statement from the, hypertension, and
hypertensive and obese patients with insulin resistance. Biol Trace obesity in the young Committee (Council on cardiovascular
Elem Res 2011;139:137–50. disease in the young) and the diabetes Committee (Council on
34. Suliburska J, Cofta S, Gajewska E, Kalmus G, Sobieska M, nutrition, physical activity, and metabolism). Circulation 2003;107:
Samborski W, et al. The evaluation of selected serum mineral 1448–53.
concentrations and their association with insulin resistance in 39. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE,
obese adolescents. Eur Rev Med Pharmacol Sci 2013;17:2396–400. Yeckel CW, et al. Obesity and the metabolic syndrome in children
35. Jose B, Jain V, Vikram NK, Agarwala A, Saini S. Serum and adolescents. N Engl J Med 2004;350(23):2362–74.
magnesium in overweight children. Indian Pediatr 2012;49:109–12. 40. Bianco A, Paoli A, Montalto M, Lamacchia G, Castelli D, Patti
36. Swaminathan R. Magnesium metabolism and its disorders. Clin A, et al. Cardiovascular risk factors in children: the importance of
Biochem Rev 2003;24:47–66. the quality of life. Exp Clin Cardiol 2014;20(1):1953–69.
37. Sothern MS, Despinasse B, Brown R, Suskind RM, Udall Jr JN, 41. Singhal V, Schwenk WF, Kumar S. Evaluation and management
Blecker U. Lipid profiles of obese children and adolescents before of childhood and adolescent obesity. Mayo Clin Proc 2007;82
and after significant weight loss: differences according to sex. (10):1258–64.
South Med J 2000;93(3):278–82.